Ethic Inc. Novo Nordisk A S Transaction History

Ethic Inc.

$3.97 Billion
Q3 2024

A detailed history of Ethic Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Ethic Inc. holds 167,817 shares of NVO stock, worth $13.2 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

167,817

Previous 181,494 7.54%

Holding current value

$13.2 Million

Previous $25.9 Million 22.87%

% of portfolio

0.5%

Previous 0.61%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$119.07 - $145.42 $1.63 Million - $1.99 Million	-13,677 Reduced 7.54%	167,817 $20 Million
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $1.68 Million - $2.01 Million	13,677 Added 8.15%	181,494 $25.9 Million
Q1 2024 May 13, 2024	BUY	$102.11 - $135.92 $147,446 - $196,268	1,444 Added 0.87%	167,817 $21.5 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $663,265 - $796,780	7,556 Added 4.76%	166,373 $17.2 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $8.17 Million - $17.9 Million	89,795 Added 130.1%	158,817 $14.4 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $100,139 - $110,841	642 Added 0.94%	69,022 $11.2 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $423,885 - $509,725	-3,203 Reduced 4.47%	68,380 $10.9 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $942,126 - $1.24 Million	9,187 Added 14.72%	71,583 $9.69 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $1.77 Million - $2.18 Million	18,609 Added 42.5%	62,396 $6.22 Million
Q2 2022 Aug 10, 2022	BUY	$103.24 - $121.81 $547,584 - $646,080	5,304 Added 13.78%	43,787 $4.88 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $1.2 Million - $1.45 Million	12,887 Added 50.35%	38,483 $4.27 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $282,750 - $345,268	2,949 Added 13.02%	25,596 $2.87 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $390,526 - $493,224	4,626 Added 25.67%	22,647 $2.17 Million
Q2 2021 Aug 10, 2021	BUY	$67.66 - $84.76 $204,536 - $256,229	3,023 Added 20.16%	18,021 $1.51 Million
Q1 2021 May 13, 2021	BUY	$67.06 - $75.82 $7,913 - $8,946	118 Added 0.79%	14,998 $1.01 Million
Q4 2020 Feb 10, 2021	BUY	$63.89 - $73.8 $13,097 - $15,129	205 Added 1.4%	14,880 $1.04 Million
Q3 2020 Oct 27, 2020	BUY	$63.69 - $70.22 $315,265 - $347,589	4,950 Added 50.9%	14,675 $1.02 Million
Q2 2020 Aug 12, 2020	BUY	$58.54 - $67.94 $55,905 - $64,882	955 Added 10.89%	9,725 $637,000
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $95,457 - $125,025	1,930 Added 28.22%	8,770 $528,000
Q4 2019 May 22, 2020	BUY	$49.86 - $58.26 $101,265 - $118,326	2,031 Added 42.23%	6,840 $396,000
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $239,776 - $280,172	4,809 New	4,809 $278,000

Others Institutions Holding NVO

# of Institutions

1,852

Shares Held

335M

Call Options Held

6.9M

Put Options Held

7.82M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $178B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account